{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:42:21Z","timestamp":1764240141037},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jns.2018.04.029","type":"journal-article","created":{"date-parts":[[2018,4,21]],"date-time":"2018-04-21T14:01:15Z","timestamp":1524319275000},"page":"139-149","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated meta-analysis"],"prefix":"10.1016","volume":"390","author":[{"given":"Hong-Bo","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haigang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuju","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanhuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2018.04.029_bb0005","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1212\/CPJ.0000000000000086","article-title":"Cryptogenic stroke a diagnostic challenge","volume":"4","author":"Yaghi","year":"2014","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jns.2018.04.029_bb0010","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","article-title":"Prevalence of patent foramen ovale in patients with stroke","volume":"318","author":"Lechat","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2018.04.029_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(88)92944-3","article-title":"Patent foramen ovale in young stroke patients","volume":"332","author":"Webster","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2018.04.029_bb0020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-117-6-461","article-title":"Patent foramen ovale as a risk factor for cryptogenic stroke","volume":"117","author":"Di Tullio","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2018.04.029_bb0025","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.110.961920","article-title":"Paradoxical embolism","volume":"122","author":"Maron","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2018.04.029_bb0030","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1161\/STROKEAHA.110.595140","article-title":"Is patent foramen ovale a modifiable risk factor for stroke recurrence?","volume":"41","author":"Kent","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2018.04.029_bb0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/hrt.2003.019315","article-title":"Indications for the closure of patent foramen ovale","volume":"90","author":"Landzberg","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jns.2018.04.029_bb0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ccd.26518","article-title":"Long-term follow-up after PFO device closure: outcomes and complications in a single-center experience","volume":"89","author":"Taggart","year":"2017","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.jns.2018.04.029_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003470","article-title":"Propensity score\u2013based analysis of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale","volume":"9","author":"Pezzini","year":"2016","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.jns.2018.04.029_bb0050","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2012.02.021","article-title":"Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism","volume":"5","author":"Agarwal","year":"2012","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jns.2018.04.029_bb0055","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2004.05.044","article-title":"Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke","volume":"44","author":"Windecker","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jns.2018.04.029_bb0060","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2018.04.029_bb0065","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2018.04.029_bb0070","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2018.04.029_bb0075","article-title":"Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack","volume":"8","author":"Li","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jns.2018.04.029_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004282","article-title":"Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale","volume":"4","author":"Spencer","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jns.2018.04.029_bb0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/heartjnl-2013-304394","article-title":"Stroke prevention by percutaneous closure of patent foramen ovale: a systematic review and meta-analysis","volume":"100","author":"Wolfrum","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jns.2018.04.029_bb0090","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1016\/j.ijcard.2013.07.077","article-title":"Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials","volume":"168","author":"Kwong","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jns.2018.04.029_bb0095","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cjca.2014.05.004","article-title":"Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses","volume":"30","author":"Udell","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jns.2018.04.029_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2013.11.027","article-title":"A systematic review of closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and cryptogenic stroke or transient ischemic attack","volume":"337","author":"Chen","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2018.04.029_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2013.10.030","article-title":"Transcatheter closure of patent foramen ovale does not reduce the risk of recurrent ischemic stroke versus medical therapy alone: a meta-analysis of randomized controlled trials","volume":"169","author":"Zhang","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jns.2018.04.029_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2013.08.058","article-title":"PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"169","author":"Ntaios","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jns.2018.04.029_bb0115","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hlc.2013.07.022","article-title":"Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials","volume":"22","author":"Nagaraja","year":"2013","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.jns.2018.04.029_bb0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.carrev.2013.08.010","article-title":"Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: comprehensive systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Hakeem","year":"2013","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.jns.2018.04.029_bb0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2261-13-116","article-title":"Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials","volume":"13","author":"Riaz","year":"2013","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.jns.2018.04.029_bb0130","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/WNL.0000000000002961","article-title":"Practice advisory: recurrent stroke with patent foramen ovale (update of practice parameter) report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of Neurology","volume":"87","author":"Mess\u00e9","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.04.029_bb0135","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2018.04.029_bb0140","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. Antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2018.04.029_bb0145","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Longterm outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2018.04.029_bb0150","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen Ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2018.04.029_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.jns.2018.04.029_bb0160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2018.04.029_bb0165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ccd.26518","article-title":"Long-term follow-up after PFO device closure: outcomes and complications in a single-center experience","volume":"89","author":"Taggart","year":"2017","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.jns.2018.04.029_bb0170","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/joic.12396","article-title":"Multidisciplinary assessment of PFO with substantial right-to-left shunting and medium-term follow-up after PFO device closure: a single-center experience","volume":"30","author":"He","year":"2017","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.jns.2018.04.029_bb0175","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jcin.2013.06.013","article-title":"Long-term experience and outcomes with transcatheter closure of patent foramen ovale","volume":"6","author":"Inglessis","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jns.2018.04.029_bb0180","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","article-title":"Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials","volume":"67","author":"Kent","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jns.2018.04.029_bb0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1212\/WNL.0b013e3181aa2a19","article-title":"Recurrent cerebral ischemia in medically treated patent foramen ovale a meta-analysis","volume":"73","author":"Almekhlafi","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2018.04.029_bb0190","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jcin.2014.01.170","volume":"7","author":"Elmariah","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jns.2018.04.029_bb0195","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/bmj.39136.682083.AE","article-title":"Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials","volume":"334","author":"Ferreira-Gonz\u00e1lez","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2018.04.029_bb0200","first-page":"21","article-title":"Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke","author":"Kim","year":"2017","journal-title":"J. Interv. Cardiol. Epub."},{"key":"10.1016\/j.jns.2018.04.029_bb0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1540-8183.2001.tb00745.x","article-title":"Patent foramen ovale closure in patients with transient ischemia attack\/stroke","volume":"14","author":"Sievert","year":"2001","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.jns.2018.04.029_bb0210","first-page":"365","article-title":"Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale","volume":"18","author":"Alaeddini","year":"2006","journal-title":"J. Invasive. Cardiol."},{"key":"10.1016\/j.jns.2018.04.029_bb0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000113427","article-title":"Atrial fibrillation following device closure of patent foramen ovale","volume":"111","author":"Burow","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/j.jns.2018.04.029_bb0220","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1161\/STROKEAHA.117.018501","article-title":"Safety outcomes after percutaneous transcatheter closure of patent foramen ovale","volume":"48","author":"Merkler","year":"2017","journal-title":"Stroke"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18301989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18301989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T05:25:09Z","timestamp":1534915509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18301989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":44,"alternative-id":["S0022510X18301989"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.04.029","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}